nanotainer

Theranos – Drew First Blood A friend recently posted a question on a NODD community group about Theranos and Elizabeth Holmes. He wondered if the investor community would be more cautious about the healthtech, and if there would be stringent methods of due diligence on healthtech and a cloud of suspicion. While I didn’t answer…